Neogenomics (NEO) Total Non-Current Liabilities (2016 - 2025)
Neogenomics' Total Non-Current Liabilities history spans 14 years, with the latest figure at $435.0 million for Q4 2025.
- For Q4 2025, Total Non-Current Liabilities changed 0.12% year-over-year to $435.0 million; the TTM value through Dec 2025 reached $435.0 million, changed 0.12%, while the annual FY2025 figure was $435.0 million, 0.12% changed from the prior year.
- Total Non-Current Liabilities reached $435.0 million in Q4 2025 per NEO's latest filing, down from $438.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $676.4 million in Q3 2021 to a low of $433.5 million in Q1 2025.
- Average Total Non-Current Liabilities over 5 years is $575.0 million, with a median of $641.8 million recorded in 2023.
- Peak YoY movement for Total Non-Current Liabilities: skyrocketed 265.36% in 2021, then crashed 32.47% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $674.3 million in 2021, then dropped by 3.29% to $652.1 million in 2022, then dropped by 1.33% to $643.4 million in 2023, then plummeted by 32.47% to $434.5 million in 2024, then grew by 0.12% to $435.0 million in 2025.
- Per Business Quant, the three most recent readings for NEO's Total Non-Current Liabilities are $435.0 million (Q4 2025), $438.6 million (Q3 2025), and $439.8 million (Q2 2025).